Aarron Willingham

Aarron Willingham

Company: Merck & Co

Job title: Executive Director


Building TLR7 Targeted Immune Agonists 11:30 am

Examine the scientific rationale behind targeted immune agonists (TIA) targeting TLR7 Assess the design of TIA conjugates and characterization of in vitro and in vivo functional activity Develop preclinical tools to de-risk TIAs potential for induction of immune-related adverse effectsRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.